Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06558604
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-24
Brief Title:
A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or RelapsedRefractory High-risk Mantle-cell Lymphoma
Sponsor:
None
Organization:
None
Organization Data
Organization:
None
Class:
None
Study ID:
None
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
None
Lead Sponsor Class:
None
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None